The report highlights a fundamental flaw in the process, given the states and territories can and do make budget-driven decisions to prevent the administration of CAR-T and gene therapies funded through the National Health Reform Agreement. …
Report highlights the need for change on NHRA-funded therapies
May 9, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News -
The stakes are very high on access in a contested budget environment
October 28, 2026 - - Latest News -
Managing an agreement negotiation as a 'prisoner of circumstance'
October 28, 2026 - - Latest News -
MSAC suggests minister skip HTA and make policy fix to ensure access to this technology
October 28, 2026 - - Latest News -
AusBiotech takes 15-year refund limit fight to the Senate as R&D tax bill lands
October 28, 2026 - - Latest News -
Lung scarring killing 11 Australians a day, with one in five cases traced to work
October 28, 2026 - - Latest News -
Company rebates fall for the first time in years, lifting net PBS costs
October 27, 2026 - - Latest News